Jennifer Oki
Impact in
- Aging top 5%
Papers in
-
- CRISPR and Genetic Engineering 4
- RNA and protein synthesis mechanisms 2
- Peroxisome Proliferator-Activated Receptors 1
- RNA regulation and disease 1
-
- COVID-19 Clinical Research Studies 1
- Co-authors
- Peter Lotfy (1 shared paper)Silvana Konermann (1 shared paper)Nicholas J. Brideau (1 shared paper)Maxim N. Shokhirev (1 shared paper)Patrick D. Hsu (1 shared paper)Kevin Holden (3 shared papers)Joyce Yang (1 shared paper)Nicholas A. Rossi (1 shared paper)
- Partner nations
- United States
In The Last Decade
Jennifer Oki
5 papers receiving 1.6k citations
Jennifer Oki's Hit Papers
Peers
Comparison fields: 5 of 94
- Business and International Management 78
- Aging 54
- Molecular Biology 1.2k
- Infectious Diseases 229
- Cancer Research 101
Countries citing papers authored by Jennifer Oki
This map shows the geographic impact of Jennifer Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Oki more than expected).
Fields of papers citing papers by Jennifer Oki
This network shows the impact of papers produced by Jennifer Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Oki. The network helps show where Jennifer Oki may publish in the future.
Co-authors
The 25 scholars most cited alongside Jennifer Oki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors Hit paper breakdown → | 2018 | 843 |
| 2 | Inference of CRISPR Edits from Sanger Trace Data Hit paper breakdown → | 2022 | 372 |
| 3 | 2020 | 264 | |
| 4 | 2021 | 80 | |
| 5 | 2023 | 6 |
About Jennifer Oki
Jennifer Oki is a scholar working on Molecular Biology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Animal Science and Zoology and Oncology, having authored 5 papers that have together received 1.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), COVID-19 Clinical Research Studies (1 paper), Viral Infections and Immunology Research (1 paper), CAR-T cell therapy research (1 paper), Virus-based gene therapy research (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Business and International Management (78 citations), Aging (54 citations), Molecular Biology (1.2k citations), Infectious Diseases (229 citations) and Cancer Research (101 citations). Jennifer Oki has collaborated with scholars based in United States. Frequent co-authors include Peter Lotfy, Silvana Konermann, Nicholas J. Brideau, Maxim N. Shokhirev, Patrick D. Hsu, Kevin Holden, Joyce Yang, Nicholas A. Rossi, Reed Kelso and Brittany L. Enzmann. Their work appears in journals such as Cell, The CRISPR Journal and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.